Andrea James - Mar 26, 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Chief Financial Officer
Signature
/s/ Andrea James
Stock symbol
OCX
Transactions as of
Mar 26, 2025
Transactions value $
$0
Form type
4
Date filed
3/28/2025, 04:05 PM
Previous filing
Feb 11, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Restricted Stock Units Award $0 +113K $0.00 113K Mar 26, 2025 Common Stock 113K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the restricted stock units will vest on each of the one-, two-, three- and four-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.